TY - JOUR
T1 - Number and brightness analysis to study spatio-temporal distribution of the angiotensin II AT1 and the endothelin-1 ETA receptors
T2 - Influence of ligand binding
AU - Planes, Nadir
AU - Digman, Michelle A
AU - Vanderheyden, Patrick P M L
AU - Gratton, Enrico
AU - Caballero-George, Catherina
N1 - Copyright © 2019. Published by Elsevier B.V.
PY - 2019/5
Y1 - 2019/5
N2 - The angiotensin II AT1 and the endothelin 1 ETA receptors play a crucial role in the pathogenesis of cardiovascular diseases like hypertension, heart failure, stroke, pulmonary hypertension, and cardiac hypertrophy. Both receptors are members of the rhodopsion-like superfamily of G protein-coupled receptors which can exist as monomers, dimers, and higher order aggregates. Recently, oligomerization of these two receptors have been described by several biophysical methods based mainly on luminescence and fluorescence energy transfer. Since this oligomerization can occur either spontaneously or it can be induced by ligand-binding, the aim of this work was to address whether the oligomerization of these receptors occurs upon ligand-binding. For this purpose the Number and Brightness analysis, a method that allows the identification, localization, and quantification of protein aggregates in the plasma membrane of a single cell, was used. An advantage of this method is that it is not limited to certain dyes specially required for Fluorescence Resonance Energy Transfer measurements. Our results showed that stably transfected angiotensin II AT1 receptors and transiently transfected endothelin 1 ETA receptors, were found as monomeric, dimeric, and tetrameric receptor aggregates. Interestingly, the binding of antihypertensive agents like losartan and BQ123, earlier suggested to be inverse agonists, significantly increased the proportion of monomers and reduced the occurrence of dimers on the cell membrane; while the kown endothelin 1 ETA antagonist sitaxentan did not influence the aggregation state of these receptors.
AB - The angiotensin II AT1 and the endothelin 1 ETA receptors play a crucial role in the pathogenesis of cardiovascular diseases like hypertension, heart failure, stroke, pulmonary hypertension, and cardiac hypertrophy. Both receptors are members of the rhodopsion-like superfamily of G protein-coupled receptors which can exist as monomers, dimers, and higher order aggregates. Recently, oligomerization of these two receptors have been described by several biophysical methods based mainly on luminescence and fluorescence energy transfer. Since this oligomerization can occur either spontaneously or it can be induced by ligand-binding, the aim of this work was to address whether the oligomerization of these receptors occurs upon ligand-binding. For this purpose the Number and Brightness analysis, a method that allows the identification, localization, and quantification of protein aggregates in the plasma membrane of a single cell, was used. An advantage of this method is that it is not limited to certain dyes specially required for Fluorescence Resonance Energy Transfer measurements. Our results showed that stably transfected angiotensin II AT1 receptors and transiently transfected endothelin 1 ETA receptors, were found as monomeric, dimeric, and tetrameric receptor aggregates. Interestingly, the binding of antihypertensive agents like losartan and BQ123, earlier suggested to be inverse agonists, significantly increased the proportion of monomers and reduced the occurrence of dimers on the cell membrane; while the kown endothelin 1 ETA antagonist sitaxentan did not influence the aggregation state of these receptors.
KW - Angiotensin II/metabolism
KW - Animals
KW - Binding Sites/drug effects
KW - CHO Cells
KW - Cricetulus
KW - Endothelin-1/agonists
KW - Fluorescence Resonance Energy Transfer
KW - Humans
KW - Isoxazoles/pharmacology
KW - Ligands
KW - Losartan/pharmacology
KW - Peptides, Cyclic/pharmacology
KW - Protein Aggregates/drug effects
KW - Receptor, Endothelin A/metabolism
KW - Thiophenes/pharmacology
U2 - 10.1016/j.bbagen.2019.03.004
DO - 10.1016/j.bbagen.2019.03.004
M3 - Article
C2 - 30851407
VL - 1863
SP - 917
EP - 924
JO - BBA General Subjects
JF - BBA General Subjects
SN - 0304-4165
IS - 5
ER -